Prestige Consumer Healthcare Cash Flow Statement
PBH / Health Care|15 years of annual SEC 10-K data (FY2012-FY2026)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Prestige Consumer Healthcare generated $249M in operating cash flow and $239M in free cash flow in FY2026. Free cash flow margin was 21.3% of revenue.
Based on SEC 10-K filings.
| Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $209.3M | - | $214.6M | $164.7M | $142.3M | -$35.8M | $339.6M | $69.4M | $99.9M | $339.6M | $69.4M | $99.9M | $78.3M | $72.6M | $29.2M |
| Depreciation & Amortization | $30.7M | - | $30.2M | $30.2M | $29.0M | $31.8M | $33.4M | $25.8M | $23.7M | $33.4M | $25.8M | $23.7M | $17.7M | $13.5M | $10.1M |
| Operating Cash Flow | $248.9M | - | $251.5M | $235.6M | $217.1M | $189.3M | $210.1M | $148.7M | $176.3M | $210.1M | $148.7M | $176.3M | $156.3M | $111.6M | $86.7M |
| Capital Expenditures | $9.6M | - | $8.2M | $22.2M | $14.6M | $10.5M | $12.5M | $3.0M | $3.6M | $12.5M | $3.0M | $3.6M | $6.1M | $2.8M | $655.0K |
| Free Cash Flow | $239.4M | - | $243.3M | $213.4M | $202.6M | $178.8M | $197.6M | $145.7M | $172.7M | $197.6M | $145.7M | $172.7M | $150.2M | $108.8M | $86.0M |
| Share Buybacks | $25.0M | - | $51.5M | $11.9M | $56.7M | $50.0M | $0 | $0 | - | $0 | $0 | - | - | - | - |
| Dividends Paid | - | - | - | - | - | - | - | - | - | - | - | $0 | $0 | $0 | $0 |
| FCF Margin | 21.3% | - | 21.4% | 22.6% | 21.0% | 18.3% | 19.0% | 14.9% | 21.4% | 19.0% | 16.5% | 21.4% | 21.0% | 18.3% | 25.6% |